These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35885714)

  • 1. COVID-19-Related Mortality amongst Physicians in Italy: Trend Pre- and Post-SARS-CoV-2 Vaccination Campaign.
    Modenese A; Loney T; Gobba F
    Healthcare (Basel); 2022 Jun; 10(7):. PubMed ID: 35885714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of COVID-19 and Vaccination Coverage in the Italian Population as of October 2021.
    Altobelli E; Marzi F; Angelone AM; Mazzocca R; Mastrodomenico M; Petrocelli R; Marziliano C
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

  • 4. Mandate or Not Mandate: Knowledge, Attitudes, and Practices of Italian Occupational Physicians towards SARS-CoV-2 Immunization at the Beginning of Vaccination Campaign.
    Riccò M; Ferraro P; Peruzzi S; Balzarini F; Ranzieri S
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
    Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
    Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with SARS-CoV-2 Infection Risk among Healthcare Workers of an Italian University Hospital.
    Modenese A; Casolari L; Rossi G; Della Vecchia E; Glieca F; D'Elia C; Garavini D; Righi E; Mariani S; Venturelli L; Vivoli D; Gobba F
    Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between average monthly high temperatures and COVID-19-related death rates in different geographical areas.
    Benedetti F; Pachetti M; Marini B; Ippodrino R; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Jun; 18(1):251. PubMed ID: 32576227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anti-COVID-19 vaccination campaign in the Metropolitan Area of Milan (Lombardy Region, Northern Italy).
    Russo AG; Tunesi S; Consolazio D; Decarli A; Bergamaschi W
    Epidemiol Prev; 2021; 45(6):568-579. PubMed ID: 34791867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
    Giordano G; Colaneri M; Di Filippo A; Blanchini F; Bolzern P; De Nicolao G; Sacchi P; Colaneri P; Bruno R
    Nat Med; 2021 Jun; 27(6):993-998. PubMed ID: 33864052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Italian Healthcare Workers From the Initial Sacrifice to the mRNA Vaccine: Pandemic Chrono-History, Epidemiological Data, Ethical Dilemmas, and Future Challenges.
    Nioi M; Napoli PE; Lobina J; Fossarello M; d'Aloja E
    Front Public Health; 2020; 8():591900. PubMed ID: 33553091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccine Hesitancy and Early Adverse Events Reported in a Cohort of 7,881 Italian Physicians.
    Monami M; Gori D; Guaraldi F; Montalti M; Nreu B; Burioni R; Mannucci E
    Ann Ig; 2022; 34(4):344-357. PubMed ID: 34821928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of health policies and vaccine rollout on the COVID-19 pandemic waves in Italy.
    Reno C; Sanmarchi F; Stoto MA; Fantini MP; Lenzi J; Golinelli D
    Health Policy Technol; 2022 Jun; 11(2):100604. PubMed ID: 35186670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.
    Mattiuzzi C; Lippi G
    Eur J Public Health; 2022 Apr; 32(2):328-330. PubMed ID: 34978571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV2 Vaccination Adverse Events Trend in Italy: A Retrospective Interpretation of the Last Year (December 2020-September 2021).
    Fazio ND; Delogu G; Bertozzi G; Fineschi V; Frati P
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.